Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ARC Trauma, LLC is an innovative medical device company founded in 2019 to develop point-of-injury emergency care solutions. The company's flagship products, the Arterial Restriction Clamp (ARC) and the Laryngoscope Junctional-Arterial Restriction Clamp (L-ARC), received FDA 510(k) clearance in December 2025. These lightweight, multifunctional devices are designed to control traumatic neck bleeding by occluding the carotid artery without restricting other parts of the neck, freeing combat medics and emergency responders to treat other casualties. The L-ARC version integrates a laryngoscope to assist medical providers in securing a patient's airway while managing severe hemorrhage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ARC Trauma.